May2023

eyesON | Decentralized Clinical Trials Outlook: USA

May 29, 2023|Comments Off on eyesON | Decentralized Clinical Trials Outlook: USA

Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.

May2023

Embracing the Future: FDA’s New Draft Guidance on Decentralized Clinical Trials

May 12, 2023|Comments Off on Embracing the Future: FDA’s New Draft Guidance on Decentralized Clinical Trials

Dive into the FDA's latest draft guidance on Decentralized Clinical Trials and the role of Risk-Based Quality Management. Learn how RBQM and centralized monitoring can elevate your clinical research efficiency and reliability.

May2023

Big Pharma M&As: Is It Worth the Trouble?

May 10, 2023|Comments Off on Big Pharma M&As: Is It Worth the Trouble?

Big Pharma M&As: A Worthwhile Challenge? Navigating the complex landscape of M&As in the pharmaceutical industry comes with unique objectives and potential benefits. But do these transactions truly drive shareholder value for the acquiring firm?

Apr2023

Global Impact of COVID-19 Pandemic on Clinical Trials

April 19, 2023|Comments Off on Global Impact of COVID-19 Pandemic on Clinical Trials

Wondering how the COVID-19 pandemic has impacted clinical trials worldwide? The COVID-19 pandemic has brought unprecedented challenges to the healthcare industry worldwide. The clinical trial sector has been no exception, and it has [...]

Apr2023

Cyntegrity Unveils Online Learning: Empowering Clinical Trial Professionals

April 19, 2023|Comments Off on Cyntegrity Unveils Online Learning: Empowering Clinical Trial Professionals

We're excited to announce the launch of Cyntegrity's new online learning platform, MyRBQM Academy. As a pioneer in providing intelligent RBQM technology solutions, we believe that education is the first step in transitioning to a new way of working in clinical research.

Apr2023

FDA releases updated guidelines for risk-based approaches to monitoring

April 14, 2023|Comments Off on FDA releases updated guidelines for risk-based approaches to monitoring

FDA Guidance: A Risk-Based Approach to Monitoring of Clinical Investigations (Q&A) The FDA has published a new guidance document titled "A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers Guidance for [...]

Mar2023

eyesON | COVID-19: Global Impact on Clinical Trials

March 24, 2023|Comments Off on eyesON | COVID-19: Global Impact on Clinical Trials

Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.

Mar2023

Revolutionizing Clinical Data Management in the US: A Look at the Past, Present, and Future

March 24, 2023|Comments Off on Revolutionizing Clinical Data Management in the US: A Look at the Past, Present, and Future

Discover how clinical data management in the US has transformed from data collection to a multi-faceted endeavor, driving breakthroughs in biomedical research, diagnostics, drug development, and vaccines. Learn from leading experts, including our Chief Scientific Officer, about the latest advancements and future prospects in this groundbreaking publication.